ENTITY

Insulet Corp (PODD US)

87
Analysis
Health CareUnited States
Insulet Corporation is a medical device company that develops, manufactures and markets an insulin infusion system for people with insulin-dependent diabetes.
more
bullishNws Holdings
02 Oct 2023 00:13

Merger Arb Mondays (02 Oct) - NWS, Mason, IMAX China, Keiyo, System Info, Toyo, Symbio, Allkem

This week, the highest gross spreads are Keiyo (58.3%), 111 (40.8%), Eoflow (22.4%), Symbio (19.3%), IMAX China (19.0%), JSR (8.3%), Boustead...

Logo
3.9k Views
Share
bullishENM Holdings
25 Sep 2023 00:21

Merger Arb Mondays (25 Sep) - ENM, Poly Culture, Eoflow, Origin Energy, Symbio, Costa, InvoCare

This week, the highest gross spreads are 111 (48.9%), Eoflow (23.7%), Symbio (10.7%), Mason Group (9.0%), JSR (7.8%), DDH1 (6.0%), ENM (5.5%),...

Logo
632 Views
Share
21 Sep 2023 16:49

Tandem Diabetes Care (TNDM US): Q2 Sales Declined, Margin Deteriorated; 2023 Guidance Revised Lower

​Tandem's Q2 sales declined 2% YoY to $195.9M, as global pump shipment plummeted 8% YoY to 29,494. The company has lowered 2023 sales guidance to...

Logo
454 Views
Share
bullishInsulet Corp
15 Sep 2023 14:00

Insulet Corporation: Launch of Omnipod 5 & Other Major Developments

Insulet Corporation exceeded analyst expectations in terms of revenue as well as earnings. The company's revenue for the second quarter surpassed...

Logo
412 Views
Share
bearishEoflow
11 Sep 2023 00:28

Merger Arb Mondays (11 Sep) - Eoflow, Mason, Liontown, Newcrest, United Malt, OreCorp, MPI

This week, the highest gross spreads are 111 (39.7%), Costa (22.8%), Eoflow (18.3%), Symbio (17.3%), Mason (9.0%), Origin Energy (8.1%), JSR...

Logo
506 Views
Share
x